1. New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
   Marica Garziera et al, 2019, Cells CrossRef
2. Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
   Minhong Tang et al, 2023, Investigational New Drugs CrossRef
3. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
   Wanqing Wang et al, 2023, Frontiers in Pharmacology CrossRef
4. Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells
   Lin Lin et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
5. Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors
   Mihai I. Truica et al, 2021, Cancer Research CrossRef
6. Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
   Peng Ding et al, 2023, Genes & Diseases CrossRef
7. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
   Huiying Han et al, 2019, Cancer Cell CrossRef
8. Synaptic Protein Degradation Controls Sexually Dimorphic Circuits through Regulation of DCC/UNC-40
   Yehuda Salzberg et al, 2020, Current Biology CrossRef
9. The Role of FBXW7 in Gynecologic Malignancies
   Riccardo Di Fiore et al, 2023, Cells CrossRef
10. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
    Bethsebie Lalduhsaki Sailo et al, 2019, Cancers CrossRef
11. The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
    Rohan Kar et al, 2021, Cancer Reports CrossRef
12. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination
    Hongge Zhu et al, 2022, Laboratory Investigation CrossRef
13. Putative E3 ligases as candidates controlling BRASSINOSTEROID INSENSITIVE 2 (BIN2) kinase in Arabidopsis
    Yu Jeong Jeong, 2020, Plant Biotechnology Reports CrossRef
14. The E3 Ligases in Cervical Cancer and Endometrial Cancer
    Fengguang Zhai et al, 2022, Cancers CrossRef
15. Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients
    Daniel S. Roberts et al, 2019, Otology & Neurotology CrossRef
16. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation
    Reyhaneh Salehi-Tabar et al, 2019, Molecular Cancer Research CrossRef
17. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
    Irene Vázquez-Domínguez et al, 2019, Oncogene CrossRef
18. FBXW7alpha Promotes the Recovery of Traumatic Spinal Cord
    Hong Zhang et al, 2020, Current Molecular Medicine CrossRef
19. In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI‐2 and dinaciclib
    Mary Ellen Urick et al, 2018, Molecular Carcinogenesis CrossRef
20. Loss of Fbxw7 in Sertoli cells impairs testis development and causes infertility in mice†
    Hanbin Zhang et al, 2020, Biology of Reproduction CrossRef
21. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma
    Hatem El-mezayen et al, 2021, Annals of Surgical Oncology CrossRef